Trademark: 87322937
Word
REPLIMUNE
Status
Registered
Status Code
700
Status Date
Tuesday, December 12, 2017
Serial Number
87322937
Registration Number
5353768
Registration Date
Tuesday, December 12, 2017
Mark Type
4
Filing Date
Thursday, February 2, 2017
Published for Opposition
Tuesday, September 26, 2017

Trademark Owner History
Replimune Limited - Original Registrant

Classifications
5 Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and pharmaceutical substances for the treatment of infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and pharmaceutical substances used for the prevention and treatment of cancer and tumors; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response for the treatment of cancer and tumors; vaccines; immunotherapy products, namely, pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
42 Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services regarding research and development in the fields of pharmaceuticals, vaccines and medicines
In the statement, "REG. NO. UK0000320659" should be deleted, and UK0003206593 should be inserted.

Trademark Events
Feb 6, 2017
New Application Entered
Feb 7, 2017
New Application Office Supplied Data Entered
Apr 27, 2017
Assigned To Examiner
May 4, 2017
Non-Final Action Written
May 4, 2017
Notification Of Non-Final Action E-Mailed
May 4, 2017
Non-Final Action E-Mailed
Jul 11, 2017
Teas Change Of Correspondence Received
Jul 19, 2017
Teas Response To Office Action Received
Aug 4, 2017
Teas Change Of Correspondence Received
Aug 4, 2017
Teas Change Of Correspondence Received
Aug 14, 2017
Assigned To Lie
Aug 14, 2017
Teas/Email Correspondence Entered
Aug 14, 2017
Correspondence Received In Law Office
Aug 18, 2017
Preliminary/Voluntary Amendment - Entered
Aug 19, 2017
Approved For Pub - Principal Register
Sep 6, 2017
Notification Of Notice Of Publication E-Mailed
Sep 26, 2017
Published For Opposition
Sep 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2017
Registered-Principal Register
Feb 20, 2018
Teas Section 7 Request Received
Mar 28, 2018
Case Assigned To Post Registration Paralegal
Sep 10, 2018
Teas Response To Office Action-Post Reg Received
Apr 11, 2018
Post Registration Action Mailed - Sec. 7
Sep 20, 2018
Correction Under Section 7 - Processed
Sep 4, 2020
Correction Under Section 7 - Processed
Dec 12, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 6, 2023
Teas Section 8 & 15 Received
Jun 12, 2024
Case Assigned To Post Registration Paralegal

Trademark Alertz updated from USPTO on 2030-01-24